Second-tier natural antidepressants: Review and critique

Journal of Affective Disorders

Volumn 130, Issue 3, 2011, Pages 343-357

  Iovieno, Nadia ^a,b   Dalton, Elizabeth D ^a   Fava, Maurizio ^a   Mischoulon, David ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

5 Hydroxytryptophan; Chromium; Complementary and Alternative Medicine; Depression; Inositol; Rhodiola rosea

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CARBIDOPA; CHROMIUM; CHROMIUM PICOLINATE; CLOMIPRAMINE; CYCLOSPORIN; DIGOXIN; DIHYDROERGOCRISTINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; INOSITOL; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NIALAMIDE; NOMIFENSINE; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; RHODIOLA ROSEA EXTRACT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THEOPHYLLINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG; WARFARIN;

ADD ON THERAPY; ALLERGY; ARTICLE; ATYPICAL DEPRESSION; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BULIMIA; DEPRESSION; DIARRHEA; DISORIENTATION; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DYSTHYMIA; EOSINOPHILIA MYALGIA SYNDROME; FATIGUE; FLATULENCE; FLUSHING; GLUCOSE BLOOD LEVEL; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; HYPERREFLEXIA; HYPERTENSION; HYPERTHERMIA; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; MAJOR DEPRESSION; MANIA; MONOTHERAPY; MOOD DISORDER; MYOCLONUS; NAUSEA; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; PLANT ROOT; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RECOMMENDED DRUG DOSE; SEASONAL AFFECTIVE DISORDER; SEROTONIN SYNDROME; SIDE EFFECT; SOMNOLENCE; TREMOR; UNPLEASANT SENSATION; UNSPECIFIED SIDE EFFECT; VIVID DREAM; VOMITING;

EID: 79955620175     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.06.010     Document Type: Review

References (116)

1. A. Abdourahman, and J.G. Edwards Chromium supplementation improves glucose tolerance in diabetic Goto-Kakizati rats IUBMB Life 60 2008 541 548
2. J. Alino, J. Gutierrez, and M. Iglesias 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depression. A double blind controlled study Int. Pharmacopsychiatry 11 1 1976 8 15
3. J.H. Allison, and M.A. Stewart Reduces brain inositol in lithium treated rats Nat. New Biol. 233 1971 267 268
4. R.A. Anderson, N.A. Bryden, and M.M. Polansky Lack of toxicity of chromium chloride and chromium picolinate in rats J. Am. Coll. Nutr. 16 1997 273 279 (Pubitemid 27237532)
5. R.A. Anderson, N. Cheng, and N.A. Bryden Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes Diabetes 46 1997 1786 1791 (Pubitemid 27456412)
6. J. Angst, B. Woggon, and J. Schoepf The treatment of depression with L-5-Hydroxytryptophan versus imipramine. Results of two open and one double-blind study Archiv fuer Psychiatrie und Nervenkrankheiten 224 2 1977 175 186 (Pubitemid 8192460)
7. J.A. Astin, A. Marie, K.R. Pelletier, E. Hansen, and W.L. Haskell A review of the incorporation of complementary and alternative medicine by mainstream physicians Arch. Intern. Med. 158 21 1998 2303 2310 (Pubitemid 28536483)
8. M.J. Attenburrow, J. Odontiadis, and B.J. Murray Chromium treatment decreases the sensitivity of 5HT2A receptors Psychopharmacology (Berl). 159 2002 432 436 (Pubitemid 34143368)
9. J.M. Baraban, P.F. Worley, and S.H. Snyder Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium Am. J. Psychiatry 146 1989 1251 1260 (Pubitemid 19258470)
10. A.I. Barkai, D.L. Dunner, H.A. Gross, P. Mayo, and R.R. Fieve Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder Biol. Psychiatry 13 1978 65 72 (Pubitemid 8285219)
11. R.H. Belmaker, and J. Levine Inositol in the treatment of psychiatric disorders D. Mischoulon, J.F. Rosenbaum, Natural Medications for Psychiatry: Considering the Alternatives 2008 Lippincott, Williams & Wilkins Philadelphia, PA 105
12. M.J. Berridge, C.P. Downes, and M.R. Hanley Neural and developmental actions of lithium: a unifying hypothesis Cell 59 1989 411 419 (Pubitemid 19284456)
13. T.C. Birdsall 5-Hydroxytryptophan: a clinically-effective serotonin precursor Altern. Med. Rev. 3 1998 271 280 (Pubitemid 128709142)
14. V.S. Brichenko, and T.F. Skorokhodova Herbal adaptogens in rehabilitation of patients with depressions Clinical and Organizational Aspects of Early Manifestations of Nervous and Mental Diseases 1987 Barnaul 15
15. V.S. Brichenko, I.E. Kupriyanova, and T.F. Skorokhodova The use of herbal adaptogens together with tricyclic anti-depressants in patients with psychogenic depressions E.D. Goldsberg, Modern Problems of Pharmacology and Search for New Medicines vol 2 1986 Tomsk State University Press Tomsk 58 60
16. H. Brodie, R. Sack, and L. Siever Clinical studies of L-5-hydroxytryptophan in depression J. Barchas, E. Usdin, Serotonin and Behavior 1973 Academic Press NY 549 559
17. R.P. Brown, P.L. Gerbarg, and Z. Ramazanov Rhodiola rosea. A phytomedicinal overview Herbal Gram. 56 2002 40 52
18. A. Bystritsky, L. Kerwin, and J.D. Feusner A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD) J. Altern. Complement. Med. 14 2 2008 175 180 (Pubitemid 351364412)
19. W.T. Cefalu, Z.Q. Wang, X.H. Zhang, L.C. Baldor, and J.C. Russell Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle glut-4 translocation in obese, hyperinsulinemic (JCR-LA Corpulent) rats J. Nutr. 132 2002 1107 1114 (Pubitemid 34606436)
20. Q.G. Chen, Y.S. Zeng, Z.Q. Qu, J.Y. Tang, Y.J. Qin, P. Chung, R. Wong, and U. Hagg The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats Phytomedicine 16 9 2009 830 838
21. L. Cheng, M. Lumb, L. Polgár, and A.W. Mudge How can the mood stabilizer VPA limit both mania and depression? Mol. Cell. Neurosci. 29 2005 309 326
22. K.N. Chengappa, J. Levine, S. Gershon, A.G. Mallinger, A. Hardan, A. Vagnucci, B. Pollock, J. Luther, J. Buttenfield, S. Vergaille, and D.J. Kupfer Inositol as an add-on treatment for bipolar depression Bipolar Disord. 2 1 2000 47 55
23. R.S. Clements, and B. Darnell Myo-inositol content of common foods: development of a high-myo-inositol diet Am. J. Clin. Nutr. 33 1980 1954 1967
24. V. Darbinyan, A. Kteyan, A. Panossian, E. Gabrielian, G. Wikman, and H. Wagner Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty Phytomedicine 7 2000 365 371
25. V. Darbinyan, G. Aslanyan, E. Amroyan, E. Gabrielyan, C. Malmström, and A. Panossian Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression Nord. J. Psychiatry 61 5 2007 343 348 (Pubitemid 350091013)
26. Y.T. Das, M. Bagchi, D. Bagchi, and H.G. Preuss Safety of 5-hydroxy-L-tryptophan Toxicol. Lett. 150 2004 111 122 (Pubitemid 38447240)
27. J.R. Davidson, K. Abraham, K.M. Connor, and M.N. McLeod Effectiveness of chromium in atypical depression: a placebo-controlled trial Biol. Psychiatry 53 2003 261 264 (Pubitemid 36135938)
28. J.A. Den Boer, and H.G. Westenberg Behavioral, neuroendocrine and biochemical effects of 5-hydroxytrptophan administration in panic disorder Psychiatry Res. 31 1990 267 278 (Pubitemid 20102375)
29. J.P. Docherty, D.A. Sack, M. Roffman, M. Finch, and J.R. Komorowski A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving J. Psychiatr. Pract. 11 2005 302 314 (Pubitemid 41540225)
30. M.G. Duncan The effects of nutritional supplements on the treatment of depression, diabetes, and hypercholesterolemia in the renal patient J. Ren. Nutr. 9 1999 58 62
31. H. Einat, H. Karbovski, J. Korik, D. Tsalah, and R.H. Belmaker Inositol reduces depressive-like behaviors in two different animal models of depression Psychopharmacology 144 1999 158 162 (Pubitemid 29264432)
32. G. Elkins, M.H. Rajab, and J. Marcus Complementary and alternative medicine use by psychiatric inpatients Psychol. Rep. 96 2005 163 166 (Pubitemid 40405975)
33. E.A. Evins, C. Demopulos, I. Yovel, M. Culhane, J. Ogutha, L.D. Grandin, A.A. Nierenberg, and G.S. Sachs Inositol augmentation of lithium or valproate for bipolar depression Bipolar Disord. 8 2006 168 174 (Pubitemid 44026769)
34. M. Fava, and D. Mischoulon Folate in depression: efficacy, safety, differences in formulations, and clinical issues J. Clin. Psychiatry 70 Suppl 5 2009 12 17
35. FDA Impurities Confirmed in Dietary Supplement 5-Hydroxy-l-Tryptophan 1998 Food and Drug Administration USA
36. J.D. Fernstrom The effect of nutritional factors on brain amino acid levels and monoamine synthesis Fed. Proc. 35 1976 1151 1156
37. V. Fintelmann, and J. Gruenwald Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies Adv. Ther. 24 4 2007 929 939 (Pubitemid 351612266)
38. M.P. Freeman Complementary and Alternative Medicine (CAM): considerations for the treatment of major depressive disorder J. Clin. Psychiatry 70 Suppl 5 2009 4 6
39. R. Frey, D. Metzler, P. Fischer, A. Heiden, J. Scharfetter, E. Moser, and S. Kasper Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla J. Psychiatr. Res. 32 1998 411 420 (Pubitemid 28491247)
40. M. Fux, J. Levine, A. Aviv, and R.H. Belmaker Inositol treatment of obsessive-compulsive disorder Am. J. Psychiatry 153 1996 1219 1221 (Pubitemid 26299846)
41. H.J. Gijsman, J.M. van Gerven, M.L. de Kam, R.C. Schoemaker, M.S. Pieters, R. de Rijk, J. van der Post, and A.F. Cohen Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers J. Clin. Psychopharmacol. 22 2002 183 189 (Pubitemid 34289393)
42. A.R. Green, J.K. Aronson, G. Curzon, and H.F. Woods Metabolism of an oral tryptophan load: I. Effects of dose and pretreatment with tryptophan Br. J. Clin. Pharmacol. 10 1980 603 610 (Pubitemid 11243332)
43. T.L. Greer, and M.H. Trivedi Exercise in the treatment of depression Curr. Psychiatry Rep. 11 6 2009 466 472
44. C.M. Guilleminault, J.P. Cathala, and P. Castaigne Effects of 5-hydroxytryptophan on sleep of a patient with brain-stem lesion Electroencephalogr. Clin. Neurophysiol. 34 1973 177 184
45. M. Hummel, E. Standl, and O. Schnell Chromium in metabolic and cardiovascular disease Horm. Metab. Res. 39 2007 743 751 (Pubitemid 350099824)
46. Institute of Medicine, Food and Nutrition Board Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2001 National Academy Press Washington, DC
47. G.S. Kelly Rhodiola rosea: a possible plant adaptogen Altern. Med. Rev. 6 2001 293 302 (Pubitemid 32591865)
48. R.C. Kessler, J. Soukup, R.B. Davis, D.F. Foster, S.A. Wilkey, M.I. Van Rompay, and D.M. Eisenberg The use of complementary and alternative therapies to treat anxiety and depression in the United States Am. J. Psychiatry 158 2001 289 294 (Pubitemid 32116527)
49. A. Khan, A. Bhat, R. Kolts, M.E. Thase, and W. Brown Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades? CNS Neurosci. Ther. 2010 (Electronic publication ahead of print April 16, 2010)
50. R. Khanam, and K.K. Pillai Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic pathways and potassium channels Basic Clin. Pharmacol. Toxicol. 98 2006 155 159
51. H. Kim, B.M. McGrath, and P.H. Silverstone A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders-focus on magnetic resonance spectroscopy (MRS) studies Hum. Psychopharmacol. Clin. Exp. 20 2005 309 326 (Pubitemid 41093934)
52. N. Kline, and W. Sacks Treatment of depression with an MAO inhibitor followed by 5-HTP - an unfinished research project Acta Psychiatr. Scand. Suppl. 280 1980 233 241 (Pubitemid 10055019)
53. R. Lane, and D. Baldwin Selective serotonin reuptake inhibitor induced serotonin syndrome: review J. Clin. Psychopharmacol. 17 1997 208 221 (Pubitemid 27261777)
54. J. Levine Controlled trials of inositol in psychiatry Eur. Neuropsychopharmacol. 7 1997 147 155 (Pubitemid 27240348)
55. J. Levine, A. Rapaport, L. Lev, Y. Bersudsky, O. Koffman, R.H. Belmaker, J. Shaprio, and G. Agam Inositol treatment raises CSF inositol levels Brain Res. 627 1993 168 170 (Pubitemid 23309612)
56. J. Levine, T. Pomerantz, and R.H. Belmaker The effect of inositol on cognitive processes and mood states in normal volunteers Eur. Neuropsychopharmacol. 4 1994 418 419
57. J. Levine, Y. Barak, M. Gonzalves, H. Szor, A. Elizur, O. Kofman, and R.H. Belmaker Double-blind, controlled trial of inositol treatment of depression Am. J. Psychiatry 152 5 1995 792 794
58. J. Levine, L. Kurtzman, A. Rapoport, J. Zimmerman, Y. Bersudsky, J. Shapiro, R.H. Belmaker, and G. Agam CSF inositol does not predict antidepressant response to inositol J. Neural Transm. 103 1996 1457 1462 (Pubitemid 27023182)
59. J. Levine, E. Witztum, B.D. Greenberg, and Y. Barak Inositol-induced mania? Am. J. Psychiatry 153 6 1996 839
60. J. Levine, A. Mishori, M. Susnosky, M. Martin, and R.H. Belmaker Combination of inositol and serotonin reuptake inhibitors in the treatment of depression Biol. Psychiatry 45 3 1999 270 273 (Pubitemid 29100029)
61. I.B. Lishmanov, Z.V. Trifonova, A.N. Tsibin, L.V. Maslova, and L.A. Dement'eva Plasma beta-endorphin and stress hormones in stress and adaptation Biull. Eksp. Biol. Med. 103 1987 422 424 Article in Russian
62. I.B. Lishmanov, A.V. Naumova, S.A. Afanas'ev, and L.N. Maslov Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischemic and reperfusion heart damage in vitro Eksp. Klin. Farmakol. 60 1997 34 36 Article in Russian
63. P.S. Liu, and M.K. Lin Biphasic effects of chromium compounds on catecholaminesecretion from bovine adrenal medullary cells Toxicology 117 1997 45 53
64. M. Maes, M.P. Jacobs, E. Suy, M. Vandewoude, B. Minner, and J. Raus Effects of dexamethasone on the availability of l-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients Biol. Psychiatry 27 1990 854 862 (Pubitemid 20145672)
65. I. Magnussen, and M.H. Van Woert Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors Eur. J. Clin. Pharmacol. 23 1982 81 86 (Pubitemid 12061631)
66. J. Maj, M. Bijak, M. Dziedzicka-Wasylewska, R. Rogoz, Z. Rogóz, G. Skuza, and T. Tokarski The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain Psychopharmacology 127 1996 73 82 (Pubitemid 26285685)
67. L.V. Maslova, B.I. Kondrat'ev, L.N. Maslov, and I.u.B. Lishmanov The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress Eksp. Klin. Farmakol. 57 1994 61 63
68. L. Mattioli, and M. Perfumi Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice Phytother. Res. 21 2007 37 43 (Pubitemid 46173906)
69. L. Mattioli, and M. Perfumi Rhodiola rosea L. extract reduced stress and CRF-induced anorexia in rats J. Psychopharmacol. 21 7 2007 742 750 (Pubitemid 47437914)
70. M.F. McCarthy Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression: an adjuvant role for chromium picolinate? Med. Hypotheses 43 1994 247 252
71. M.N. McLeod, and R.N. Golden Chromium treatment of depression Int. J. Neuropsychopharmacol. 3 2000 311 314 (Pubitemid 32056624)
72. M.N. McLeod, B.N. Gaynes, and R.N. Golden Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients J. Clin. Psychiatry 60 1999 237 240 (Pubitemid 29193921)
73. H. Meltzer, B. Bastani, K. Jayathilake, and M. Maes Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophanmediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder Neuropsychopharmacology 17 1997 1 11 (Pubitemid 27259707)
74. W. Mertz Chromium in human nutrition: a review J. Nutr. 123 1993 626 633 (Pubitemid 23110994)
75. D.S. Ming, B.J. Hillhouse, E.S. Guns, A. Eberding, S. Xie, S. Vimalanthan, and G.H. Towers Bioactive compounds from Rhodiola rosea (Crassulaceae) Phytother. Res. 19 2005 740 743 (Pubitemid 41571421)
76. D. Mischoulon Update and critique of natural remedies as antidepressant treatments Psychiatr. Clin. N. Am. 30 2007 51 68 (Pubitemid 46386300)
77. D. Mischoulon Update and critique of natural remedies as antidepressant treatments Obstet. Gynecol. Clin. N. Am. 36 4 2009 789 807
78. D. Mischoulon, P. Pedrelli, J. Wurtman, M. Vangel, and R. Wurtman Report of two double-blind randomized placebo-controlled pilot studies of a carbohydrate-rich nutrient mixture for treatment of seasonal affective disorder (SAD) CNS Neurosci. Ther. 16 1 2010 13 24
79. C.M. Moore, J.L. Breeze, T.J. Kukes, S.L. Rose, S.R. Dager, B.M. Cohen, and P.F. Renshaw Effect of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study Biol. Psychiatry 45 1999 1197 1202 (Pubitemid 29236561)
80. M. Nardini, R. De Stefano, M. Iannuccelli, R. Borghesi, and N. Battistini Treatment of depression with l-5-hydroxytryptophan combined with chlorimipramine, a double-blind study Int. J. Clin. Pharmacol. Res. 3 1983 239 250 (Pubitemid 14207548)
81. B. Nemets, A. Mishory, J. Levine, and R.H. Belmaker Inositol addition does not improve depression in SSRI treatment failures J. Neural Transm. 106 7-8 1999 795 798 (Pubitemid 29401367)
82. M. Nicolodi, and F. Sicuteri Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy Adv. Exp. Med. Biol. 398 1996 373 379 (Pubitemid 126426254)
83. F.N. Nielso Chromium M.E. Shils, J.A. Olson, M. Shike, 8th ed Modern nutrition in health and disease vol 1 1994 Lea & Febiger Philadelphia, PA 264 268
84. A.A. Nierenberg, M.J. Ostacher, J.R. Calabrese, T.A. Ketter, L.B. Marangell, D.J. Miklowitz, S. Miyahara, M.S. Bauer, M.E. Thase, S.R. Wisniewski, and G.S. Sachs Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone Am. J. Psychiatry 163 2 2006 210 216 (Pubitemid 44480839)
85. W. Nolen, J. van de Putte, W.A. Dijken, and J.S. Kamp L-5HTP in depression resistant to reuptake inhibitors. An open comparative study with tranylcypromine Br. J. Psychiatry 147 1985 16 22 (Pubitemid 15091081)
86. W.A. Nolen, J.J. van de Putte, W.A. Dijken, J.S. Kamp, B.A. Blansjaar, H.J. Kramer, and J. Haffmans Treatment strategy in depression: II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine Acta Psychiatr. Scand. 78 6 1988 676 683 (Pubitemid 19027334)
87. Nutrition Business Journal NBJ's Supplement Business Report 2003 2003 Penton Media Inc. San Diego, CA
88. E.M. Olsson, B. von Schéele, and A.G. Panossian A randomized double-blind placebo controlled parallel group study of SHR-5 extract of Rhodiola rosea roots as treatment for patients with stress related fatigue Planta Med. 75 2 2009 102 112
89. A. Panossian, N. Nikoyan, N. Ohanyan, A. Hovhannisyan, H. Abrahamyam, E. Gabreilyan, and G. Wikman Comparative study of Rhodiola preparations on behavioral despair of rats Phytomedicine 15 2008 84 91
90. A. Panossian, A. Hovhannisyan, H. Abrahamyan, E. Gabrielyan, and G. Wikman Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats Phytother. Res. 23 2009 351 357
91. S. Phaneuf, G. Europe-Finner, M. Carrasco, C.H. Hamilton, and A. López Bernal Oxytocin signaling in human myometrium Adv. Exp. Med. Biol. 395 1995 453 467
92. A. Piotrowska, K. Mlyniec, A. Siwek, M. Dybala, W. Opoka, E. Poleszak, and G. Nowak Antidepressant-like effect of chromium chloride in the mouse forced swim test: involvement of glutamatergic and serotonergic receptors Pharmacol. Rep. 60 2008 991 995
93. W. Poldinger, B. Calanchini, and W. Schwarz A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine Psychopathology 24 2 1991 53 81
94. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatments Eur. J. Pharmacol. 47 4 1978 379 391
95. Y.J. Qin, Y.S. Zeng, C.C. Zhou, Y. Li, and Z.Q. Zhong Effects of Rhodiola rosea on level of 5-hydoxytryptaine, cell proliferation and differentiation, and number of neurons in cerebral hippocampus of rats with depression induced by chronic mild stress Chung Kuo Chung Yao Tsa Chih 33 23 2008 2842 2846
96. H. Quadbeck, E. Lehmann, and J. Tegeler Comparison of the antidepressant action of tryptophan, tryptophan/5-hydroxytryptophan combination and nomifensine Neuropsychobiology 11 2 1984 111 115 (Pubitemid 14088298)
97. B.D. Ross Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites NMR Biomed. 4 1991 59 63
98. J. Rousseau Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double blind, placebo controlled clinical trial in elderly patients Clin. Ther. 9 3 1987 267 272 (Pubitemid 17072926)
99. K. Shaw, J. Turner, and C. Del Mar Tryptophan and 5-hydroxytryptophan for depression Cochrane Database Syst. Rev. 1 2002 CD003198
100. H. Shimon, G. Agam, R.H. Belmaker, T.M. Hyde, and J.E. Kleinman Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder Am. J. Psychiatry 154 1997 1148 1150 (Pubitemid 27328834)
101. P.H. Silverstone, R.H. Wu, T. O'Donnell, M. Ulrich, S.J. Asghar, and C.C. Hanstock Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients Hum. Psychopharmacol. Clin. Exp. 17 2002 321 327 (Pubitemid 35189813)
102. C.A. Smith, P.P. Hay, and H. Macpherson Acupuncture for depression Cochrane Database Syst. Rev. 1 2010 CD004046
103. A.A. Spasov, G.K. Wikman, V.B. Mandrikov, I.A. Mironova, and W. Neumoin A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen Phytomedicine 7 2000 85 89 (Pubitemid 30307605)
104. A.F. Thachil, R. Mohan, and D. Bhugra The evidence base of complementary and alternative therapies in depression J. Affect. Disord. 97 1-3 2007 23 35 (Pubitemid 44963511)
105. J. Thomson, H. Rankin, G.W. Ashcroft, C.M. Yates, J.K. McQueen, and S.W. Cummings The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo Psychol. Med. 12 1982 741 751 (Pubitemid 13174843)
106. E.H. Turner, J.M. Loftis, and A.D. Blackwell Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan Pharmacol. Ther. 109 2006 325 338 (Pubitemid 43132816)
107. J. Unützer, R. Klap, R. Sturm, A.S. Young, T. Marmon, J. Shatkin, and K.B. Wells Mental disorders and the use of alternative medicine: results from a national survey Am. J. Psychiatry 157 2000 1851 1857
108. D. Van Diermen, A. Marston, J. Bravo, M. Reist, P.A. Carrupt, and K. Hostettmann Monoamine oxidase inhibition by Rhodiola rosea L. roots J. Ethnopharmacol. 122 2009 397 401
109. L.J. van Hiele L-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions Neuropsychobiology 6 1980 230 240 (Pubitemid 10156639)
110. H.M. van Praag, and S. de Haan Chemoprophylaxis of depressions. An attempt to compare lithium with 5-hydroxytryptophan Acta Psychiatr. Scand. Suppl. 290 1981 191 201 (Pubitemid 11156111)
111. H.M. van Praag, and C. Lemus Monoamine precursors in the treatment of psychiatric disorders R.J. Wurtman, J.J. Wurtman, Nutrition and the Brain 1986 Raven Press NY 89 139
112. H.M. van Praag, J. Korf, L.C. Dols, and T. Schut A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant Psychopharmacology 25 1972 14 21
113. H.G. Westenberg, T.W. Gerritsen, B.A. Meijer, and H.M. van Praag Kinetics of l-5-hydroxytryptophan in healthy subjects Psychiatry Res. 27 3 1982 373 385 (Pubitemid 13172082)
114. R.S. Williams, L. Cheng, A.W. Mudge, and A.J. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 417 2002 292 295 (Pubitemid 34534711)
115. M. Wolfson, Y. Bersudsky, E. Zinger, M. Simkin, R.H. Belmaker, and L. Hertz Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations Brain Res. 855 2000 158 161 (Pubitemid 30067707)
116. K. Zmilacher, R. Battegay, and M. Gastpar L-5-Hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression Neuropsychobiology 20 1988 28 35 (Pubitemid 19059598)